Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| AT&T | 4.14% | $16.57M | $183.33B | 10.96% | 72 Outperform | |
| Verizon | 4.04% | $16.16M | $171.14B | -8.54% | 72 Outperform | |
| PepsiCo | 4.02% | $16.07M | $199.78B | -9.90% | 78 Outperform | |
| Altria Group | 4.01% | $16.05M | $97.93B | 1.30% | 64 Neutral | |
| Merck & Company | 3.22% | $12.87M | $262.25B | 3.98% | 76 Outperform | |
| Alphabet Class A | 2.97% | $11.87M | $3.90T | 91.12% | 80 Outperform | |
| Colgate-Palmolive | 2.79% | $11.17M | $64.34B | -18.02% | 63 Neutral | |
| Philip Morris | 2.76% | $11.05M | $245.03B | 19.41% | 62 Neutral | |
| US Bancorp | 2.71% | $10.83M | $76.03B | -8.54% | 75 Outperform | |
| Pfizer | 2.70% | $10.82M | $146.24B | -0.19% | 68 Neutral |